FUROSEMIDE
| Brand name | LASIX ONYU |
|---|---|
| Active ingredient | FUROSEMIDE |
| Strength | 80MG/2.67ML (30MG/ML) |
| Dosage form | SOLUTION |
| Route | SUBCUTANEOUS |
| Modality | Small molecule |
| FDA approval | October 2025 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 12403120 | January 2042 | product |
| 11246851 | January 2040 | product |
| 12318363 | January 2040 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.